Cited by 556PI3K/AKT/mTOR signaling in cancerSignaling Pathways in DiseaseProtein Kinase Regulation and GTPase Signaling

Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.

Open access
Chen, J, Zheng, X F, Brown, E J, Schreiber, S L·1995·Proceedings of the National Academy of Sciences

Abstract

Complexed with its intracellular receptor, FKBP12, the natural product rapamycin inhibits G1 progression of the cell cycle in a variety of mammalian cell lines and in the yeast Saccharomyces cerevisae. Previously, a mammalian protein that directly associates with FKBP12-rapamycin has been identified and its encoding gene has been cloned from both human (designated FRAP) [Brown, E.J., Albers, M.W., Shin, T.B., Ichikawa, K., Keith, C.T., Lane, W.S. & Schreiber, S.L. (1994) Nature (London) 369, 756-758] and rat (designated RAFT) [Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. (1994) Cell 78, 35-43]. The full-length FRAP is a 289-kDa protein containing a putative phosphatidylinositol kinase domain. Using an in vitro transcription/translation assay method coupled with proteolysis studies, we have identified an 11-kDa FKBP12-rapamycin-binding domain within FRAP. This minimal binding domain lies N-terminal to the kinase domain and spans residues 2025-2114. In addition, we have carried out mutagenesis studies to investigate the role of Ser2035, a potential phosphorylation site for protein kinase C within this domain. We now show that the FRAP Ser2035-->Ala mutant displays similar binding affinity when compared with the wild-type protein, whereas all other mutations at this site, including mimics of phosphoserine, abolish binding, presumably due to either unfavorable steric interactions or induced conformational changes.

Integrity signals

Registry

Crossref · 10.1073/pnas.92.11.4947

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The mTOR kinase N-lobe features a large insertion corresponding to the FKBP12-rapamycin binding (FRB) domain specific to mTORC1 among the PIKKs.

    “Notably, however, the kinase N-lobe features a large insertion corresponding to the FKBP12-rapamycin binding (FRB) domain (Chen et al., 1995; Chiu et al., 1994; Vilella-Bach et al., 1999) specific to mTORC1 among the PIKKs.”

    From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Chen et al., 1995

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chen, J., Zheng, X. F., Brown, E. J., & Schreiber, S. L.
Affiliations
Howard Hughes Medical Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
1995-05-23
Volume
92
Issue
11
Pages
4947-4951
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1987005832
Cited by
556
References
30
Citations by year
2026: 9 · 2025: 7 · 2024: 22 · 2023: 19 · 2022: 15 · 2021: 19 · 2020: 11 · 2019: 20 · 2018: 17 · 2017: 26 · 2016: 18 · 2015: 29 · 2014: 19 · 2013: 27 · 2012: 30
FWCI
3.60
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • Damon Runyon Cancer Research Foundation
  • Harvard University
  • National Institutes of Health
  • National Institute of General Medical Sciences (GM38627)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
FRAP, FKBP12, rapamycin, protein kinase C phosphorylation sites, protein phosphorylation, protein conformational change, G1 cell cycle arrest
MeSH terms
Amino Acid Sequence, Animals, Binding Sites, Carrier Proteins, Circular Dichroism, Cloning, Molecular, DNA-Binding Proteins, Heat-Shock Proteins, Humans, Immunosuppressive Agents, Kinetics, Mammals, Molecular Sequence Data, Molecular Weight, Peptide Fragments, Polyenes, Protein Conformation, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Serine, Transcription, Genetic, Protein Biosynthesis, Mutagenesis, Site-Directed, Tacrolimus, Sirolimus, Tacrolimus Binding Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review